TruScreen Group Limited (TRU) is a medical device company that has developed and manufactures an AI-enabled device for detecting abnormalities in the cervical tissue in real-time via measurements of the low level of optical and electrical stimuli. Its cervical screening technology enables cervical screening, negating sampling and processing of biological tissues, failed samples, missed follow-up, discomfort, and the need for costly personnel and supporting laboratory infrastructure.
Find out what a historical investment in Truscreen Group would be worth today using our TRU stock calculator.
Buying TRU shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Truscreen Group in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in TRU
What is the ticker symbol of Truscreen Group?
The ticker symbol for Truscreen Group is TRU.
How much is one share of TRU?
One share of TRU is valued at $0.01 as of 22 November 2026.
What is the market capitalisation of Truscreen Group TRU?
As of 22 November 2026 Truscreen Group has a market cap of $7.33M.
What is the P/E ratio of TRU?
The Price to Earnings ratio of TRU is -2.41.
What is the Earnings Per Share of TRU?
The Earnings Per Share of TRU is -$0.00.
What is the 52-week high for Truscreen Group stock?
The Truscreen Group 52-week high stock price is $0.02.
What is the 52-week low for Truscreen Group stock?
The Truscreen Group 52-week low stock price is $0.01.
Can I buy TRU shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TRU shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.